These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

614 related items for PubMed ID: 11345196

  • 1. Molecular biology of chronic myeloid leukemia.
    Maru Y.
    Int J Hematol; 2001 Apr; 73(3):308-22. PubMed ID: 11345196
    [Abstract] [Full Text] [Related]

  • 2. [The Philadelphia chromosome: from the gene to therapeutic methods].
    Pérez-Losada J, González-Sarmiento R, Sánchez-García I.
    Sangre (Barc); 1998 Apr; 43(2):127-35. PubMed ID: 9656774
    [No Abstract] [Full Text] [Related]

  • 3. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
    Gutiérrez-Castellanos S, Cruz M, Rabelo L, Godínez R, Reyes-Maldonado E, Riebeling-Navarro C.
    Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759
    [Abstract] [Full Text] [Related]

  • 4. Molecular pathogenesis of chronic myeloid leukemia: implications for new therapeutic strategies.
    Warmuth M, Danhauser-Riedl S, Hallek M.
    Ann Hematol; 1999 Feb; 78(2):49-64. PubMed ID: 10089019
    [Abstract] [Full Text] [Related]

  • 5. Philadelphia chromosome-positive leukaemia: the translocated genes and their gene products.
    Allen PB, Morgan GJ, Wiedemann LM.
    Baillieres Clin Haematol; 1992 Oct; 5(4):897-930. PubMed ID: 1308169
    [Abstract] [Full Text] [Related]

  • 6. BCR-ABL, ABL-BCR, BCR, and ABL genes are all expressed in individual granulocyte-macrophage colony-forming unit colonies derived from blood of patients with chronic myeloid leukemia.
    Diamond J, Goldman JM, Melo JV.
    Blood; 1995 Apr 15; 85(8):2171-5. PubMed ID: 7718887
    [Abstract] [Full Text] [Related]

  • 7. Structural organization of BCR-ABL gene in chronic phase and blast transformation in chronic myeloid leukemia patients.
    Martinelli G, Zaccaria A, Farabegoli P, Buzzi M, Testoni N, Bragliani M, Panzica G, Tura S.
    Leuk Lymphoma; 1993 Apr 15; 11 Suppl 1():51-6. PubMed ID: 8251917
    [Abstract] [Full Text] [Related]

  • 8. The molecular biology of chronic myeloid leukaemia.
    Melo JV.
    Leukemia; 1996 May 15; 10(5):751-6. PubMed ID: 8656667
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Induced dendritic cell differentiation of chronic myeloid leukemia blasts is associated with down-regulation of BCR-ABL.
    Lindner I, Kharfan-Dabaja MA, Ayala E, Kolonias D, Carlson LM, Beazer-Barclay Y, Scherf U, Hnatyszyn JH, Lee KP.
    J Immunol; 2003 Aug 15; 171(4):1780-91. PubMed ID: 12902478
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mechanisms of transformation by the BCR/ABL oncogene.
    Sattler M, Griffin JD.
    Int J Hematol; 2001 Apr 15; 73(3):278-91. PubMed ID: 11345193
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Gadd45a deficiency accelerates BCR-ABL driven chronic myelogenous leukemia.
    Mukherjee K, Sha X, Magimaidas A, Maifrede S, Skorski T, Bhatia R, Hoffman B, Liebermann DA.
    Oncotarget; 2017 Feb 14; 8(7):10809-10821. PubMed ID: 28086219
    [Abstract] [Full Text] [Related]

  • 17. Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia.
    Barnes DJ, Palaiologou D, Panousopoulou E, Schultheis B, Yong AS, Wong A, Pattacini L, Goldman JM, Melo JV.
    Cancer Res; 2005 Oct 01; 65(19):8912-9. PubMed ID: 16204063
    [Abstract] [Full Text] [Related]

  • 18. Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: a novel model for chronic myelogenous leukemia.
    Zhang X, Ren R.
    Blood; 1998 Nov 15; 92(10):3829-40. PubMed ID: 9808576
    [Abstract] [Full Text] [Related]

  • 19. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.
    Wilson MB, Schreiner SJ, Choi HJ, Kamens J, Smithgall TE.
    Oncogene; 2002 Nov 21; 21(53):8075-88. PubMed ID: 12444544
    [Abstract] [Full Text] [Related]

  • 20. Molecular and cellular bases of chronic myeloid leukemia.
    Chen Y, Peng C, Li D, Li S.
    Protein Cell; 2010 Feb 21; 1(2):124-32. PubMed ID: 21203982
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.